Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about HIV
Recent news which mentions HIV
The Health of the Healthcare System
August 13, 2025
Tags
Doc Gumshoe
Eli Lilly (LLY)
Novo Nordisk (NVO)
From
Stock Gumshoe
Midsummer Shorties from Doc Gumshoe
July 17, 2025
Tags
Artificial Intelligence // A/I/
Gilead (GILD)
Alzheimer's Disease
From
Stock Gumshoe
Gilead's Lenacapavir Plan Faces Global Hurdles As It Commits To No-Profit Access for 2 Million
July 09, 2025
Tickers
GILD
NEWS
Tags
Market News
Health Care
Expert Ideas
From
Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
July 05, 2025
Tickers
FNV
GILD
JCI
NOC
Tags
HIV
USFD
Long Ideas
From
Benzinga
Pfizer And GSK's ViiV Healthcare's Two-Drug HIV Treatment Matches Gilead's Three-Drug Combo In Major Trial
July 23, 2024
Tickers
GILD
GSK
NEWS
PFE
Tags
PFE
General
HIV
From
Benzinga
Blood Stains on UK after Shocking Scandal. Questions Demand Answers
May 31, 2024
Tags
Education
London, Greater
Iron Deficiency
From
PRLog
Crucial Battle Over Healthcare Mandates: Biden Administration Defends Preventive Care Coverage Amidst Legal Challenges
March 04, 2024
Tickers
GILD
GSK
NEWS
PFE
Tags
Market News
Health Care
Biden Administration
From
Benzinga
Bill Gates Reflects On Nelson Mandela's Efforts: 'Global Health Stands On The Shoulders Of His Immense Legacy'
July 18, 2023
Tags
HIV
General
News
From
Benzinga
Blockchain-Powered Project Targeting HIV Treatment In Africa Raises $2M From VCs
September 16, 2022
Tags
HIV
General
Top Stories
From
Benzinga
Catching Up on COVID and Keeping Up to Date on Monkeypox
August 24, 2022
Tags
coronavirus
Monkeypox
Pfizer (PFE)
From
Stock Gumshoe
Ashley Innes Relishes Opportunity to Make Her Mark on HIV Epidemic in Southern U.S.
August 19, 2022
Tags
Responsible Business & Employee Engagement
Health & Healthcare
Gilead
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Connecting Through Crisis
August 02, 2022
Tickers
CVX
Tags
Huma Abbasi
Philanthropy & Cause Initiatives
AIDS 2022
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Are HIV Patients Who Use Cannabis At Greater Risk For Heart Disease? This Cardiologist Was Granted $2.3M To Find Out
July 07, 2022
Tags
Benzinga
Education
Market News
From
Benzinga
At the Forefront of HIV Health and Healing in Spain: Ferran's Story
April 06, 2022
Tags
Philanthropy & Cause Initiatives
Gilead
Health & Healthcare
From
3BL Media: Corporate Social Responsibility, Energy and Health News
FDA Approves ViiV Healthcare's Cabenuva For Virologically Suppressed Adolescents With HIV
March 29, 2022
Tickers
GSK
JNJ
PFE
Tags
Market News
JNJ
Health Care
From
Benzinga
How This HIV Activist Prioritizes Wellness in His Day-to-Day
March 15, 2022
Tickers
MRK
Tags
Merck
Health & Healthcare
NYSE: MRK
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Gilead's Lenacapavir Shows Sustained Efficacy In Pretreated HIV Patients
February 17, 2022
Tickers
GILD
Tags
GILD
HIV treatment
Briefs
From
Benzinga
Did Umbilical Cord Blood Transplant Help Cure A Woman's HIV infection?
February 15, 2022
Tickers
CO
Tags
Penny Stocks
Market News
Health Care
From
Benzinga
Ending HIV-Related Stigma in the Southern United States: Gina's Story
February 11, 2022
Tags
Gilead Sciences
HIV
Diversity & Inclusion
From
3BL Media: Corporate Social Responsibility, Energy and Health News
HIV in the Time of COVID-19: The Case for Investment
January 28, 2022
Tags
Health & Healthcare
NYSE:GILD
Gilead Sciences
From
3BL Media: Corporate Social Responsibility, Energy and Health News
IAVI, Moderna Kickstart HIV Vaccine Antigens Trial Delivered Through mRNA Technology
January 27, 2022
Tickers
MRNA
Tags
Briefs
Benzinga
Biotech
From
Benzinga
Improving HIV Care With Telehealth
January 26, 2022
Tags
Health & Healthcare
Innovation & Technology
NYSE:GILD
From
3BL Media: Corporate Social Responsibility, Energy and Health News
Proceeds From Apple's RED Gizmos To Be Used To Fight COVID-19 In Sub-Saharan Africa
January 05, 2022
Tickers
AAPL
AMZN
BAC
SBUX
Tags
Covid/19
BAC
AAPL
From
Benzinga
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option
December 21, 2021
Tickers
GSK
PFE
Tags
Health Care
Market News
Biotech
From
Benzinga
Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection
December 07, 2021
Tickers
MRK
Tags
Health Care
Market News
HIV treatment
From
Benzinga
Merck Pauses Development Of MK-8507 In HIV Infection
November 19, 2021
Tickers
MRK
Tags
Biotech
Benzinga
HIV treatment
From
Benzinga
ViiV Healthcare's Dovato Combo Regime Shows Encouraging Long Term Data In HIV Patients
September 29, 2021
Tickers
GSK
PFE
Tags
Briefs
News
HIV
From
Benzinga
Theratechnologies' IV Push Form Of HIV Treatment At Par With IV Infusion
September 22, 2021
Tickers
THTX
Tags
Movers
Health Care
Market News
From
Benzinga
Why Are Indaptus Therapeutics Shares Shooting Higher On Wednesday?
September 15, 2021
Tickers
INDP
Tags
Market News
Movers
Health Care
From
Benzinga
Johnson & Johnson Stops HIV Vaccine Trial In African Women
August 31, 2021
Tickers
JNJ
Tags
Briefs
Benzinga
Phase 2 Trial
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.